Pnc Financial Services Group, Inc. Verastem, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.92 - $11.16 $1,737 - $21,081	-1,889 Reduced 69.96%	811 $0
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $137 - $247	-135 Reduced 4.76%	2,700 $3,000
Q1 2022 May 12, 2022	BUY	$1.06 - $2.1 $143 - $283	135 Added 5.0%	2,835 $3,000
Q3 2020 Nov 06, 2020	SELL	$1.11 - $1.68 $11,100 - $16,800	-10,000 Reduced 78.74%	2,700 $3,000
Q2 2020 Aug 07, 2020	BUY	$1.69 - $4.2 $16,900 - $42,000	10,000 Added 370.37%	12,700 $21,000
Q1 2018 May 11, 2018	BUY	$2.92 - $3.81 $3,212 - $4,191	1,100 Added 68.75%	2,700 $0
Q4 2017 Feb 09, 2018	BUY	$2.99 - $4.85 $4,784 - $7,759	1,600	1,600 $0

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.